Efficacy and Safety of Nerivio Device for Acute Treatment of Migraine in People With Chronic Migraine

NACompletedINTERVENTIONAL
Enrollment

126

Participants

Timeline

Start Date

November 18, 2019

Primary Completion Date

May 22, 2020

Study Completion Date

August 30, 2020

Conditions
Chronic Migraine
Interventions
DEVICE

Nerivio

A remote electrical neuromodulation (REN) device for the acute treatment of migraines.The device delivers transcutaneous electrical stimulation to the upper arm to induce conditioned pain modulation (CPM) that activates a descending endogenous analgesic mechanism. The treatment is self-administered and controlled by a smartphone application.

Trial Locations (10)

11803

Island Neurological, Plainview

15220

Preferred Primary Care Physicians, Inc., Pittsburgh

37203

Nashville neuroscience, Nashville

39157

Headache Neurology Research Institute, Ridgeland

63141

Mercy Hospital, St Louis

63303

StudyMetrix Research, LLC, City of Saint Peters

65810

ClinVest, Springfield

90404

California Medical Clinic for Headache, Santa Monica

92663

Newport Beach Clinical Research Associates, Inc., Newport Beach

06102

Hartford Healthcare Center, Hartford

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Theranica

INDUSTRY

NCT04194008 - Efficacy and Safety of Nerivio Device for Acute Treatment of Migraine in People With Chronic Migraine | Biotech Hunter | Biotech Hunter